Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth

Keyphrases

• Estradiol 100%
• Cardiac Fibroblasts 100%
• Fibroblast Growth 100%
• Inhibitory Effect 27%
• Metabolism 27%
• Catechol-O-methyltransferase 27%
• Cytochrome P450 (CYP450) 27%
• Quercetin 27%
• DNA Synthesis 18%
• Estrogen Receptor 18%
• Collagen Synthesis 18%
• Heart Disease 9%
• Cardiac Remodeling 9%
• 2-methoxyestradiol 9%
• Receptor-independent 9%
• Inhibitor-1 9%
• 3H-thymidine Incorporation 9%
• Proline 9%
• Cell number 9%
• Isoproterenol 9%
• Catechol-O-methyltransferase Inhibitors 9%
• Estrogen Metabolites 9%
• 1-aminobenzotriazole 9%
• Inducer 9%
• Phenobarbital 9%
• 3-methylcholanthrene 9%
• Cytochrome P450 Inhibitors 9%
• Estrogen Receptor Binding 9%
• Potent Inhibitor 9%
• Cardiac Fibroblast Activation 9%
• Receptor Binding Affinity 9%
• Independent Pathway 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Diethylstilbestrol 100%
• Estradiol 3 Methyl Ether 100%
• Estriol 41%
• Catechol 33%
• Estrogen Receptor 25%
• Methyltransferase 25%
• 3,5 Dinitropyrocatechol 25%
• Quercetin 25%
• Noradrenalin 8%
• Heart Disease 8%
• Heart Ventricle Remodeling 8%
• 2 Hydroxyestradiol 8%
• Proline 8%
• Thymidine 8%
• Methyltransferase Inhibitor 8%
• Isoprenaline 8%
• Phenobarbital 8%
• Methylcholanthrene 8%
• 1 Aminobenzotriazole 8%
• Cytochrome 8%